Trials / Completed
CompletedNCT03250390
Breath Analysis to Diagnose Lung Cancer
Analysis of Volatile Organic Compounds in Exhaled Air as a Diagnostic Tool for Thoracic Cancers
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 1,500 (actual)
- Sponsor
- University Hospital, Lille · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Determination of volatile organic compounds to discriminate patients with lung cancer from healthy smokers and non-smokers healthy subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Collection of volatile organic compounds during exhalation | The volatile organic compounds (VOCs) are collected in sorbents at rest and at the end of exhalation according to the concentration of carbon dioxide using ReCIVA breath sampler. The identification of the VOCs will be done by chromatography (Gas Chromatography Mass Spectrometry GC-MS) |
Timeline
- Start date
- 2019-04-29
- Primary completion
- 2024-04-29
- Completion
- 2024-04-29
- First posted
- 2017-08-15
- Last updated
- 2025-04-15
Locations
7 sites across 1 country: France
Source: ClinicalTrials.gov record NCT03250390. Inclusion in this directory is not an endorsement.